妊娠期糖代谢异常早期干预对巨大儿发生率效果分析

目的：对妊娠期糖代谢异常的早期规范治疗巨大儿的发生率效果进行分析。方法：将2008年1月～2010年1月在我所进行定期检查糖代谢异常的孕妇142例随机分为两组,同意规范治疗设为干预组（80例）,不同意规范治疗设为对照组（62例）。结果：两组围生儿结局的比较,差异有统计学意义（P〈0.05、P〈0.01）。巨大儿组孕妇空腹血糖、餐后2 h血糖较正常体重儿组孕妇更高,差异有统计学意义（P〈0.05）。结论：早期规范治疗妊娠期糖代谢异常,有效降低巨大儿的发生率,有助于减少母儿并发症。

Effect analysis of early intervention in glycometablism abnormality on the incidence of fetal macrosomia in gestation

Objective： To analyze the effect of early standardized treatment in glycometablism abnormality on the incidence of fetal macrosomia in gestation.Methods： 142 cases of pregnant women from January 2008 to January 2010 periodically checked for glycometablism abnormality in our Clinic were divided into 2 groups,the ones agreed with standard treatment were set to the intervention group（80 cases）,others disagreed with the standard treatment were set to the control group（62 cases）.Results： There were significant differences on the neonates outcomes in two groups（P〈0.05,P〈0.01）.Fasting blood-glucose and blood-glucose after meal in fetal macrosomia group were higher than those of the pregnant women with normal fetus group,there were significant differences（P〈0.05）.Conclusion： Early standardized treatment of glycometablism abnormality in pregnant could reduce the incidence of fetal macrosomia,and reduce the complication of mother-fetus.